Cyclophosphamide
DrugBank ID: DB00531
Summary
| Metric | Value |
|---|---|
| Total Predictions | 55 |
| KG+DL (Dual Validated) | 6 |
| DL Only | 44 |
| KG Only | 5 |
Predictions
| Indication | Score | Source |
|---|---|---|
| lymphosarcoma | 0.9954 | KG+DL |
| myeloid leukemia | 0.9947 | DL |
| ganglioneuroblastoma (disease) | 0.9943 | DL |
| neuroblastoma | 0.9938 | KG+DL |
| vertebral anomalies and variable endocrine and T-cell dysfunction | 0.9938 | DL |
| retroperitoneal neoplasm | 0.9937 | DL |
| lymph node cancer | 0.9931 | DL |
| primary cutaneous T-cell lymphoma | 0.9926 | DL |
| lymphoma, non-Hodgkin, familial | 0.9878 | DL |
| acute lymphoblastic leukemia (disease) | 0.9867 | DL |
| myelodysplastic syndrome | 0.9864 | DL |
| unclassified myelodysplastic syndrome | 0.9864 | DL |
| refractory cytopenia of childhood | 0.9859 | DL |
| B-cell neoplasm | 0.9854 | DL |
| aregenerative anemia | 0.9849 | DL |
| colon adenocarcinoma | 0.9848 | DL |
| mantle cell lymphoma | 0.9846 | DL |
| partial deletion of the long arm of chromosome 5 | 0.9838 | DL |
| severe congenital hypochromic anemia with ringed sideroblasts | 0.9835 | DL |
| follicular lymphoma | 0.9800 | DL |
| localized pagetoid reticulosis | 0.9799 | KG+DL |
| acute lymphoblastic/lymphocytic leukemia | 0.9788 | DL |
| primary cutaneous B-cell lymphoma | 0.9782 | DL |
| Sezary syndrome | 0.9766 | DL |
| blast phase chronic myelogenous leukemia, BCR-ABL1 positive | 0.9741 | DL |
| chronic lymphocytic leukemia/small lymphocytic lymphoma with immunoglobulin heavy chain variable-region gene somatic hypermutation | 0.9728 | DL |
| pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma | 0.9728 | DL |
| lymphoma | 0.9727 | DL |
| indolent plasma cell myeloma | 0.9703 | DL |
| primary cutaneous T-cell non-Hodgkin lymphoma | 0.9697 | DL |
| interdigitating dendritic cell sarcoma | 0.9693 | DL |
| small intestinal Burkitt lymphoma | 0.9688 | DL |
| plasma cell myeloma | 0.9683 | KG+DL |
| neoplasm of mature B-cells | 0.9681 | DL |
| malignant phyllodes tumor | 0.9667 | DL |
| subcutaneous panniculitis-like T-cell lymphoma | 0.9662 | DL |
| small intestinal mucosa-associated lymphoid tissue lymphoma | 0.9657 | DL |
| lymphoid neoplasm | 0.9651 | DL |
| breast mucosa-associated lymphoid tissue lymphoma | 0.9650 | DL |
| primary organ-specific lymphoma | 0.9649 | DL |
| reticulum cell sarcoma | 0.9649 | DL |
| tonsillar lymphoma | 0.9646 | DL |
| thyroid gland mucosa-associated lymphoid tissue lymphoma | 0.9642 | DL |
| follicular lymphoma, susceptibility to, 1 | 0.9629 | DL |
| mycosis fungoides and variants | 0.9624 | KG+DL |
| indolent primary cutaneous T-cell lymphoma | 0.9611 | DL |
| folliculotropic mycosis fungoides | 0.9540 | KG+DL |
| Ewing sarcoma | 0.9506 | DL |
| precursor lymphoblastic lymphoma/leukemia | 0.9478 | DL |
| malignant breast phyllodes tumor | 0.9465 | DL |
Showing top 50 of 55 predictions.
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.